Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (FY)Feb 29, 2024 | (FY)Feb 28, 2023 | (FY)Feb 28, 2022 | (FY)Feb 28, 2021 | (FY)Feb 28, 2019 | (FY)Feb 28, 2018 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | 1.03%6.87M | 23.72%6.8M | 18.52%5.5M | -22.18%4.64M | 5.96M | -2.46%4.74M | 4.86M |
| Net profit before non-cash adjustment | 21.30%10.52M | 35.01%8.67M | -7.15%6.42M | 13.44%6.92M | --6.1M | 7.88%5.19M | --4.81M |
| Total adjustment of non-cash items | -62.41%-3.91M | -644.84%-2.41M | 53.22%-322.89K | 43.81%-690.19K | ---1.23M | 87.16%-25.42K | ---197.99K |
| -Depreciation and amortization | 31.06%384K | 15.01%293K | 32.40%254.76K | 3.77%192.41K | --185.42K | 10.21%169.69K | --153.97K |
| -Reversal of impairment losses recognized in profit and loss | -83.66%25K | --153K | --0 | ---- | --7.06K | ---- | ---- |
| -Assets reserve and write-off | --0 | 87.03%-3K | ---23.13K | --0 | ---65.84K | ---- | ---- |
| -Disposal profit | -49.66%-4.57M | -290.65%-3.05M | 27.51%-781.52K | 28.92%-1.08M | ---1.52M | 48.04%-184.47K | ---355.05K |
| -Net exchange gains and losses | 200.00%35K | -29.80%-35K | 67.08%-26.97K | -108.33%-81.92K | ---39.32K | -1,960.47%-48.76K | --2.62K |
| -Other non-cash items | -8.75%219K | -5.50%240K | -8.44%253.97K | 37.87%277.39K | --201.2K | 7,977.75%38.13K | --472 |
| Changes in working capital | -51.78%257K | 188.30%533K | 62.02%-603.65K | -245.89%-1.59M | --1.09M | -271.52%-424.45K | --247.46K |
| -Change in receivables | 126.18%189K | -193.60%-722K | 175.42%771.39K | -367.30%-1.02M | --382.64K | -145.46%-373.27K | --821.09K |
| -Change in inventory | 87.83%216K | -79.37%115K | 134.41%557.37K | -40,091.51%-1.62M | --4.05K | -31.01%-188.46K | ---143.85K |
| -Change in payables | -112.98%-148K | 158.99%1.14M | -283.52%-1.93M | 49.81%1.05M | --702.86K | 131.94%137.27K | ---429.78K |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | |||||||
| Interest received (cash flow from operating activities) | 57.14%33K | 21K | 0 | -12.93%902 | 1.04K | ||
| Tax refund paid | 2.83%-1.44M | -14.29%-1.49M | 5.64%-1.3M | -19.00%-1.38M | -1.16M | -9.90%-1.2M | -1.09M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 2.32%5.46M | 27.14%5.34M | 28.72%4.2M | -32.10%3.26M | --4.8M | -6.03%3.55M | --3.77M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | -528.53%-2.31M | -1,172.82%-368K | 108.47%34.3K | -67.93%-405.08K | ---241.23K | 87.98%-197.67K | ---1.64M |
| Net investment product transactions | 28.01%-3.37M | -5.89%-4.68M | -62.91%-4.42M | 26.57%-2.71M | ---3.69M | 173.78%1.47M | ---1.99M |
| Dividends received (cash flow from investment activities) | 35.53%679K | 20.72%501K | 15.92%415K | 140.54%358.01K | --148.84K | 301.09%89.76K | --22.38K |
| Investing cash flow | -10.03%-5M | -14.53%-4.55M | -43.85%-3.97M | 27.12%-2.76M | ---3.79M | 137.65%1.36M | ---3.61M |
| Financing cash flow | |||||||
| Net issuance payments of debt | 92.99%-23K | -56.56%-328K | -200.40%-209.51K | -227.38%-69.74K | ---21.3K | 71,921.49%1.27M | ---1.77K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --100 | --0 |
| Increase or decrease of lease financing | ---- | ---- | ---- | ---- | ---- | --0 | ---20K |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---6M | ---- |
| Interest paid (cash flow from financing activities) | 3.45%-252K | -2.77%-261K | 8.44%-253.97K | -37.87%-277.39K | ---201.2K | -2,488.13%-39.03K | ---1.51K |
| Financing cash flow | 53.31%-275K | -27.08%-589K | -33.51%-463.48K | -56.01%-347.14K | ---222.5K | -20,369.63%-4.77M | ---23.28K |
| Net cash flow | |||||||
| Beginning cash position | 23.17%1.26M | -18.13%1.02M | 8.53%1.25M | 232.65%1.15M | --346.1K | 15.29%1.06M | --920.87K |
| Current changes in cash | -9.00%182K | 184.50%200K | -254.33%-236.7K | -80.64%153.37K | --792.17K | -0.94%140.46K | --141.79K |
| Effect of exchange rate changes | -191.89%-34K | 273.62%37K | 117.94%9.9K | -522.84%-55.2K | --13.05K | 3,497.57%33.53K | ---987 |
| End cash Position | 11.75%1.41M | 23.20%1.26M | -18.15%1.02M | 8.53%1.25M | --1.15M | 16.39%1.24M | --1.06M |
| Free cash flow | -36.65%3.15M | 19.73%4.97M | 45.31%4.15M | -36.70%2.86M | --4.51M | 54.85%3.3M | --2.13M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.